Kobayashi S, Seki T, Nonomura K, Tanaka H, Gotoh T, Togashi M, Koyanagi T
Department of Urology, Hokkaido University School of Medicine.
Nihon Hinyokika Gakkai Zasshi. 1990 Dec;81(12):1849-56. doi: 10.5980/jpnjurol1989.81.1849.
The adrenal function mainly cortical one, was evaluated in 16 patients with incidentally discovered adrenal masses. Pathological examination was possible in 15 cases. The finding consisted of adrenocortical adenoma in 9, adrenocortical nodular hyperplasia in 1, adrenal medullary hyperplasia in 1, metastatic tumor in 2 and adrenal cyst in 2. Another case of adrenal cyst was diagnosed by percutaneous puncture. In all cases peripheral levels of plasma cortisol, plasma aldosterone concentration and plasma renin activity were normal. Plasma catecholamine levels were also normal except in a case of adrenal medullary hyperplasia. On the other hand, the cases of adrenocortical adenoma displayed elevation of urinary 17-hydroxycorticosteroids in 6/9 (67%), a loss of plasma cortisol circadian rhythm in 3/7 (43%) and insufficient suppression on dexamethasone (DXM) suppression test in 6/9 (67%). Their adrenal scintigraphy (with 131I-6 beta-iodomethyl-9-nor-cholest-5 (10)-en-3 beta-ol) revealed an increased ipsilateral up-take and insufficient suppression after DXM in all, while a diminished contralateral up-take in 4/9 (44%). These data suggested that a considerable number of adrenal incidentalomas may not be truly "non-functioning". Two patients with cortical adenoma experienced post operative adrenal insufficiency (25%). It was suggested that a pre-operative loss of plasma cortisol circadian rhythm was the most prognosticating of the post operative adrenal insufficiency, rather than insufficient DXM suppression or scintigraphic absence of contralateral up-take. Among the patients with malignancy, differentiation of incidental adrenal adenoma from metastasis by size alone may not be reliable.
对16例偶然发现肾上腺肿块的患者评估了肾上腺功能,主要是皮质功能。15例患者可行病理检查。检查结果包括:肾上腺皮质腺瘤9例,肾上腺皮质结节性增生1例,肾上腺髓质增生1例,转移瘤2例,肾上腺囊肿2例。另有1例肾上腺囊肿经皮穿刺确诊。所有病例的外周血皮质醇水平、血浆醛固酮浓度和血浆肾素活性均正常。除1例肾上腺髓质增生患者外,血浆儿茶酚胺水平也正常。另一方面,肾上腺皮质腺瘤患者中,6/9(67%)尿17-羟皮质类固醇升高,3/7(43%)血浆皮质醇昼夜节律消失,6/9(67%)地塞米松(DXM)抑制试验抑制不足。肾上腺闪烁显像(用131I-6β-碘甲基-9-去甲胆甾-5(10)-烯-3β-醇)显示,所有患者患侧摄取增加,DXM后抑制不足,而4/9(44%)对侧摄取减少。这些数据表明,相当一部分肾上腺偶发瘤可能并非真正“无功能”。2例皮质腺瘤患者术后出现肾上腺功能不全(25%)。提示术前血浆皮质醇昼夜节律消失是术后肾上腺功能不全最具预后价值的因素,而非DXM抑制不足或闪烁显像对侧摄取缺失。在恶性肿瘤患者中,仅根据大小区分肾上腺偶发腺瘤与转移瘤可能不可靠。